Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.

Vascular Aging: Implications for Cardiovascular Disease and Therapy

Open access

Abstract

The incidence and prevalence of cardiovascular disease is highest among the elderly, in part, due to deleterious effects of advancing age on the heart and blood vessels. Aging, a known cardiovascular risk factor, is progressively associated with structural and functional changes to the vasculature including hemodynamic disturbance due to increased oxidative stress, premature cellular senescence and impairments in synthesis and/or secretion of endothelium-derived vasoactive molecules. These molecular and physiological changes lead to vessel wall stiffening and thickening, as well as other vascular complications that culminate to loss of vascular tone regulation and endothelial function. Intriguingly, the vessel wall, a biochemically active structure composed of collagen, connective tissue, smooth muscle and endothelial cells, is adversely affected by processes involved in premature or normal aging. Notably, the inner most layer of the vessel wall, the endothelium, becomes senescent and dysfunctional with advancing age. As a result, its ability to release vasoactive molecules such as acetylcholine (ACh), prostacyclin (PGI2), endothelium-derived hyperpolarizing factor (EDHF), and nitric oxide (NO) is reduced and the cellular response to these molecules is also impaired. By contrast, the vascular endothelium increases its generation and release of reactive oxygen (ROS) and nitrogen (RNS) species, vasoconstrictors such as endothelin (ET) and angiotensin (AT), and endogenous inhibitors of NO synthases (NOSs) to block NO. This skews the balance of the endothelium in favor of the release of highly tissue reactive and harmful molecules that promote DNA damage, telomere erosion, senescence, as well as stiffened and hardened vessel wall that is prone to the development of hypertension, diabetes, atherosclerosis and other cardiovascular risk factors. This Review discusses the impact of advancing age on cardiovascular health, and highlights the cellular and molecular mechanisms that underlie age-associated vascular changes. In addition, the role of pharmacological interventions in preventing or delaying age-related cardiovascular disease is discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4172/2161-1025.1000183

Cites

150 of 150 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Senescence and rejuvenation of vascular endothelium. A) Aging or vascular injury contributes to endothelial dysfunction and senescence including increased endothelial permeability, over-proliferation of smooth muscle cells (SMCs), adhesion of inflammatory monocytes, accumulation of reactive oxygen species (ROS), peroxynitrite (OONO−), and inflammatory cytokines. In addition, the number of endothelial precursor cell reserve such as endothelial progenitor cells (EPCs) and endothelial colony-forming cells (ECFCs) is markedly reduced. In B) a rejuvenated vascular endothelium, as a result of pharmacological intervention, characterized by continuous monolayer of endothelial cells and production of beneficial vasoactive molecules such as nitric oxide (NO), as well as enriched EPCs and ECFCs is shown.
Figure 1 Senescence and rejuvenation of vascular endothelium. A) Aging or vascular injury contributes to endothelial dysfunction and senescence including increased endothelial permeability, over-proliferation of smooth muscle cells (SMCs), adhesion of inflammatory monocytes, accumulation of reactive oxygen species (ROS), peroxynitrite (OONO−), and inflammatory cytokines. In addition, the number of endothelial precursor cell reserve such as endothelial progenitor cells (EPCs) and endothelial colony-forming cells (ECFCs) is markedly reduced. In B) a rejuvenated vascular endothelium, as a result of pharmacological intervention, characterized by continuous monolayer of endothelial cells and production of beneficial vasoactive molecules such as nitric oxide (NO), as well as enriched EPCs and ECFCs is shown.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 150 references

Cited by

See all 90

Metadata

Authors
Ghebre, Y. T., Yakubov, E., Wong, W. T., & Krishnamurthy, P.
Affiliations
  • Baylor College of Medicine (US)
  • Chinese University of Hong Kong (HK)
  • University of Alabama at Birmingham (US)
Venue
Translational Medicine
Published
2016
Volume
06
Issue
04
ISSN
2161-1025 (ISSN-L)
OpenAlex
W2565429613
Cited by
87
References
150
Citations by year
2026: 4 · 2025: 9 · 2024: 11 · 2023: 15 · 2022: 7 · 2021: 7 · 2020: 9 · 2019: 12 · 2018: 10 · 2017: 3
FWCI
6.86
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion, cc-by)
  • PubMed Central (acceptedVersion, cc-by)
Funders
National Heart, Lung, and Blood Institute (K01HL118683, R01HL137703)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Keywords
vascular aging, cardiovascular disease, endothelial dysfunction, cellular senescence, oxidative stress, endothelium-derived hyperpolarizing factor, nitric oxide, endothelin, angiotensin, reactive oxygen species, vascular stiffness, hypertension, atherosclerosis, diabetes mellitus, anti-aging therapy, vascular tone regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vascular Aging: Implications for Cardiovascular Disease and Therapy. https://app.cochat.ai/papers/10.4172/2161-1025.1000183
The paper
Ghebre, Y. T., Yakubov, E., Wong, W. T., & Krishnamurthy, P. (2016). Vascular Aging: Implications for Cardiovascular Disease and Therapy. Translational Medicine. https://doi.org/10.4172/2161-1025.1000183

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.